Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
Saraç, Hilal, Morova, Tunç, Pires, Elisabete, McCullagh, James, Kaplan, Anıl, Cingöz, Ahmet, Bagci-Onder, Tugba, Önder, Tamer, Kawamura, Akane, Lack, Nathan A
Published in Oncogene (01.03.2020)
Published in Oncogene (01.03.2020)
Get full text
Journal Article
Focused Screening Identifies Different Sensitivities of Human TET Oxygenases to the Oncometabolite 2‑Hydroxyglutarate
Belle, Roman, Saraç, Hilal, Salah, Eidarus, Bhushan, Bhaskar, Szykowska, Aleksandra, Roper, Grace, Tumber, Anthony, Kriaucionis, Skirmantas, Burgess-Brown, Nicola, Schofield, Christopher J., Brown, Tom, Kawamura, Akane
Published in Journal of medicinal chemistry (28.03.2024)
Published in Journal of medicinal chemistry (28.03.2024)
Get full text
Journal Article
Selective targeting of human TET1 by cyclic peptide inhibitors: Insights from biochemical profiling
Šimelis, Klemensas, Saraç, Hilal, Salah, Eidarus, Nishio, Kosuke, McAllister, Tom E., Corner, Thomas P., Tumber, Anthony, Belle, Roman, Schofield, Christopher J., Suga, Hiroaki, Kawamura, Akane
Published in Bioorganic & medicinal chemistry (01.02.2024)
Published in Bioorganic & medicinal chemistry (01.02.2024)
Get full text
Journal Article
Histologically benign PI‐RADS 4 and 5 lesions contain cancer‐associated epigenetic alterations
Şeref, Ceren, Acar, Ömer, Kılıç, Mert, Vural, Metin, Sağlıcan, Yeşim, Saraç, Hilal, Coşkun, Bilgen, İnce, Ümit, Esen, Tarık, Lack, Nathan A.
Published in The Prostate (01.01.2022)
Published in The Prostate (01.01.2022)
Get full text
Journal Article
Determining the origin of synchronous multifocal bladder cancer by exome sequencing
Acar, Ömer, Özkurt, Ezgi, Demir, Gulfem, Saraç, Hilal, Alkan, Can, Esen, Tarık, Somel, Mehmet, Lack, Nathan A
Published in BMC cancer (09.11.2015)
Published in BMC cancer (09.11.2015)
Get full text
Journal Article
Intensity-Modulated Radiation Therapy Improves the Target Coverage Over 3-D Planning While Meeting Lung Tolerance Doses for All Patients With Malignant Pleural Mesothelioma
Ulger, Sukran, Cetin, Eren, Catli, Serap, Sarac, Hilal, Kilic, Diclehan, Bora, Huseyin
Published in Technology in cancer research & treatment (01.06.2017)
Published in Technology in cancer research & treatment (01.06.2017)
Get full text
Journal Article